Trade Mark 2207455 | IP Australia

NIDLEGY

Class 5:: Pharmaceutical, biopharmaceutical and veterinary preparations for the treatment of cancers, including the targeting of angiogenesis; antibodies and antibody derivatives and fragments, including human monoclonal antibodies and their derivatives and fragments; pharmaceutical and veterinary preparations.

The applicant has advised that the words in the Mark have no meaning in English

No oppositions information available.

Date	Description
18 Apr 2023	Customer Amendment Made correspondence sent
18 Apr 2023	Amendment to Address for Service Requested
18 Jan 2022	International Registration in Australia Protected correspondence sent
17 Jan 2022	IP Right Registration Published	Trade mark details »
17 Jan 2022	Status change to Registered/Protected
10 Nov 2021	Application Accepted correspondence sent
10 Nov 2021	IP Right has been Examined
10 Nov 2021	IP Right Acceptance Published	Trade mark details »
09 Nov 2021	Status change to Accepted
07 Sep 2021	Awaiting examination
02 Sep 2021	IP Right Filed Published	Trade mark details »
02 Sep 2021	Status change to Published
02 Sep 2021	Status change to Filed
02 Sep 2021	Application Received
02 Sep 2021	IP right goods and service classes updated	More
	Event description Class Count: 1 Class Numbers:5 Previous details Class Count: 0 Class Numbers: New details Class Count: 1 Class Numbers: 5
02 Sep 2021	IP Right Goods and Services Items updated	More
	Event description Class Number: 5 Previous details New details Class Number: 5 Class Items: Pharmaceutical, biopharmaceutical and veterinary preparations for the treatment of cancers, including the targeting of angiogenesis; antibodies and antibody derivatives and fragments, including human monoclonal antibodies and their derivatives and fragments; pharmaceutical and veterinary preparations.
02 Sep 2021	Status change to Received
02 Sep 2021	Trade mark representation updated

Word

NIDLEGY

Image

Australian Trade Mark Search